Application of Cell Saver in OPCAB
WANG Sheng
CHENG Zhao-yun
ZHOU Sheng-kai
Abstract：Objective To compare the clinical effect of Cell Saver in OPCAB.Methods 96 cases of OPCAB patients were divided into two groups:Cell Saver group(n=48) and no Cell Saver(n=48).The red blood cell count (RBC),hemoglobin (Hb),hematocrit (Hct),platelet count (PLA),postoperative drainage,transfused heterogenous blood and adverse reactions between two groups after operation 24 hours were compared.Results Twenty-four hours after operation in the experimental group and control group,RBC were respective (3.6±0.5)× 1012/L vs (3.5±0.7)×1012/L,Hb were respective(111±12)g/L vs (110±10)g/L,Hct were respective 0.33±0.04 vs 0.32±0.04,and PLA were respective(119±21)×109/L vs (116±23)×109/L respectively;postoperative drainage were (385±45)ml vs (378±57)ml.The experimental group compared with the control group:the blood transfusion volume was (95±13)ml vs (424±58)rnl,the incidence of adverse reactions after transfusion was 6 cases vs 21 cases.There were no significant differences between the two groups in postoperative RBC,Hb,Hct,PLA,and the volume of drainage (P＞0.05),while the volume of transfused heterogenous blood and adverse reactions were significantly different(P＜0.05).Conclusion Using Cell Saver in OPCAB,the heterogenous blood transfusion and adverse reactions can be reduced obviously,with good economic and social benefits.
Keywords：Cell SaverOPCABAllogeneic blood transfusion
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 1120-1122 )